In summary, improved characterization of the functions and mechanisms of tumor-infiltrating B cells and PD-L1 not only improves knowledge of tumor immune mechanisms but also suggests potential directions for future drug development and cancer immunotherapies. The gene discussed is CD274; the disease is neoplasm.